Live Deal Pipeline
Deal detail
Browse Samjong KPMG's control sale, investment, and real-estate opportunities in one place.
Healthcare & BiotechPublished deal
Project Ginseng - Buyout
Advanced biotechnology venture with wild-ginseng tissue-culture technology and large-scale production facilities
| Location | Korea |
|---|---|
| Industry | Healthcare & Biotech |
| Revenue | Contact us |
| Asking | KRW 8–9 billion on a 100% equity basis |
| Deal structure | Sale of 100% of existing shares |
| Financials | Contact us |
Investment highlights
- Produces a range of ingredient products by drying, milling, extracting, and concentrating cultured wild-ginseng roots using patented tissue-culture technology
- Established diverse distribution channels, including listings in Korean airline duty-free catalogs
- Named Best Brand of the Year at the Korea Consumer Awards for ten consecutive years since 2016
- Opportunity to acquire the relevant technology and facilities at a comparatively attractive valuation
Deal partner
Junbo Sim, Partner